Fig. 5
ΔMTRasym difference maps showing tumor pixels with contrast enhancement at 4.3 ppm post 20 min of i.v. iopamidol administration in (a) 231-WT tumor; (b) 231-HIF-1α-shRNA tumor and; (c) 231-VEGF tumor; (d) plot showing percentage of pixels enhanced in all tumors (Values represent Mean ± S.D., n = 4).
